Cytox Ltd is an innovative developer of assays for risk assessment and prediction of dementia.

Cytox is a UK-based company with a unique scientific and proprietary technology platform that is helping to increase the understanding of the biology behind dementia risk. The focus is on the development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.